You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: January 1, 2026

Bulk Pharmaceutical API Sources for PARAGARD T 380A


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for PARAGARD T 380A

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free 203122_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 207780_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 223409_ALDRICH ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for PARAGARD T 380A

Last updated: August 11, 2025

Introduction

The PARAGARD T 380A is a non-hormonal intrauterine device (IUD) used for long-term contraception. Its primary active component is copper, which exerts local spermicidal effects to prevent pregnancy. Unlike hormonal contraceptives, PARAGARD relies solely on the copper component as its active pharmaceutical ingredient (API). Given the critical role of copper in the device's efficacy, sourcing high-quality copper suitable for medical device manufacturing is paramount. This article provides an in-depth analysis of bulk copper sources suitable for the manufacturing of PARAGARD T 380A, focusing on quality standards, global suppliers, and supply chain considerations.


Overview of the Active Ingredient: Copper in PARAGARD

The API in PARAGARD T 380A is high-purity copper, typically comprising 99.9% or higher purity (also denoted as "three nines" purity). The copper wire within the device must meet stringent specifications, including chemical composition, purity, mechanical properties, and biocompatibility.

The copper used must comply with regulatory standards such as the USP (United States Pharmacopeia), EP (European Pharmacopoeia), or JP (Japanese Pharmacopoeia). Moreover, sourcing from qualified suppliers ensures an uninterrupted supply chain and adherence to manufacturing standards.


Types of Copper Suitable for API and Medical Devices

  1. Electrolytic Copper (CU-ETP)

    • Used extensively in medical and electrical applications.
    • High purity (≥99.99%), low impurities.
  2. Oxygen-Free Copper (OFC)

    • Enhanced electrical and thermal conductivity.
    • Suitable for high-precision applications but less common in medical devices.
  3. Coppers Specially Purified for Medical Applications

    • Must meet strict biocompatibility and chemical purity standards.

The choice of copper depends on manufacturing processes, regulatory requirements, and supplier certifications.


Global Sources of Bulk Copper for API Manufacturing

1. Domestic and International Copper Producers

Major copper producers provide high-purity copper suitable for medical device manufacturing:

  • Southern Copper Corporation (Peru, Mexico): A leading global copper producer, offering electrolytic cathodes and refined copper meeting various international standards.

  • Codelco (Chile): One of the world's largest producers, with extensive grades of high-purity copper.

  • Freeport-McMoRan (USA): Supplies high-quality copper cathodes and refined copper for specialized applications.

  • Rheinische Gold- und Silber-Scheideanstalt (Germany): Supplies copper with high purity and certification.

2. Specialized Copper Suppliers for Medical-Grade Applications

Suppliers that have established quality management systems aligned with medical standards include:

  • KME Group (Italy): Offers medical-grade copper products compliant with USP and EP specifications.

  • Concast Metal Products (India): Provides high-purity copper wire suited for medical devices, certified to meet international standards.

  • Mitsubishi Metal Corporation (Japan): Supplies high-purity copper suitable for sensitive medical applications.

  • Southwire Company (USA): Offers medical-grade copper conductors with certifications for biocompatibility and high purity.


Regulatory and Quality Standards for Copper API in Medical Devices

Manufacturers sourcing copper for PARAGARD T 380A must ensure suppliers conform to:

  • USP Class VI standards for biocompatibility and purity.
  • ISO 9001 / ISO 13485 certification for quality management systems.
  • RoHS and REACH compliance to adhere to environmental safety standards.
  • Material Safety Data Sheets (MSDS) and comprehensive testing reports verifying chemical composition, impurity levels, and mechanical properties.

Supply Chain Considerations and Risk Management

Ensuring consistent supply involves:

  • Establishing partnerships with multiple certified suppliers.
  • Conducting routine supplier audits and quality assessments.
  • Verifying traceability and certification documentation.
  • Securing long-term contracts with geographic diversity to mitigate geopolitical risks.

Emerging Trends and Innovations

Advances in metal purification techniques, such as vacuum melting and electrorefining, improve the quality of copper suitable for medical devices. Additionally, developments in recycled copper sourcing, provided the purity standards are met, contribute to sustainable manufacturing.


Environmental and Ethical Sourcing

Suppliers adhering to Responsible Minerals Initiative (RMI) standards and aligned with OECD Due Diligence Guidance are preferable, ensuring ethically sourced raw materials and reducing environmental impact.


Conclusion

Copper remains the primary active pharmaceutical ingredient in PARAGARD T 380A, with high-purity electrolytic copper serving as the ideal source. Global suppliers with robust quality controls, regulatory compliance, and reliable supply chains are essential for maintaining the manufacturing integrity of the device. Strategic partnerships with certified producers ensure adherence to stringent standards, which directly impact the efficacy and safety of the final product.


Key Takeaways

  • The API in PARAGARD T 380A is high-purity, medical-grade copper, primarily obtained from electrolytic copper suppliers meeting USP and EP standards.
  • Leading global suppliers include Southern Copper, Codelco, Freeport-McMoRan, KME Group, and Concast Metal Products, among others.
  • Ensuring supplier certification, traceability, and compliance with biocompatibility standards is vital for regulatory approval and patient safety.
  • Supply chain diversification and sustainability practices enhance resilience and align with industry best practices.
  • Technological advances in purification and environmentally sustainable sourcing are shaping future supplies.

FAQs

1. What purity levels are required for copper used in PARAGARD T 380A?
Copper used must be at least 99.99% pure (three nines), meeting USP and EP specifications for medical-grade materials.

2. Are there specific certifications that suppliers must possess for supplying copper API?
Yes, suppliers should have ISO 9001 / ISO 13485, GMP compliance, and certifications verifying biocompatibility, such as USP Class VI.

3. Can recycled copper be used for manufacturing the copper components in PARAGARD?
Recycled copper can be used if it meets the strict purity standards and passes all biocompatibility and safety testing requirements.

4. How do geopolitical factors influence copper sourcing for medical devices?
Geopolitical instability, trade restrictions, and tariffs can disrupt supply chains—diversifying sources and maintaining inventory buffers mitigate these risks.

5. What are the environmental considerations in sourcing copper for medical applications?
Suppliers committed to responsible mining, fair labor practices, and environmental sustainability—adhering to RMI and OECD guidelines—are preferred.


Sources

  1. [1] U.S. Pharmacopeia. Copper Standards for Medical Devices.
  2. [2] European Pharmacopoeia. Copper Quality Specifications.
  3. [3] RMI and OECD guidelines on responsible minerals sourcing.
  4. [4] Major copper producer websites and product datasheets.
  5. [5] Industry reports on medical-grade copper manufacturing and standards.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.